Innovacell (TKS: 504A)

Tokyo, Japan · Publicly Held

Innovacell Inc is engaged in the development, manufacturing, and sale of regenerative medicine products for the treatment of conditions including fecal and urinary incontinence. Innovacell (TKS: 504A) is based in Tokyo, Japan. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $364 million (Feb 2026). It has raised $193 million.

Last price · $/share
—
Implied valuation
$364.2M
Total raised
$193.4M
Last round
—

Who backs Innovacell (TKS: 504A)?

26 investors
InvestorType
SBI InvestmentVenture capital
UntroDOther
HiJoJo PartnersVenture capital
Happiness CapitalOther
Felicity Global CapitalGrowth equity
Arcus InvestmentHedge fund
Ci:z Investment—
BuschierFamily office
ASKA Pharmaceutical Holdings—
Alfresa Holdings—
+ 16 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Innovacell (TKS: 504A) investors

26 investors are on record for Innovacell (TKS: 504A), including SBI Investment, UntroD, HiJoJo Partners and Happiness Capital.

Free account
More of Innovacell (TKS: 504A) with a free account
  • ·The complete investor list: 26 names
  • ·Watch Innovacell (TKS: 504A): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 26 firms already write checks for companies like Innovacell (TKS: 504A). Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View